Workflow
Cross ntry Healthcare(CCRN)
icon
Search documents
Cross ntry Healthcare(CCRN) - 2024 Q1 - Earnings Call Transcript
2024-05-02 01:50
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q1 2024 Results Conference Call May 1, 2024 5:00 PM ET Company Participants Joshua Vogel - Vice President of Investor Relations John Martins - President, CEO & Director Bill Burns - Executive VP & CFO Marc Krug - Group President of Delivery Conference Call Participants Trevor Romeo - William Blair Brian Tanquilut - Jefferies A.J. Rice - UBS Bill Sutherland - Benchmark Company Constantine Davides - Citizens JMP Tobey Sommer - Truist Securities Kevin Steinke - Barr ...
Compared to Estimates, Cross Country (CCRN) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research· 2024-05-02 00:36
For the quarter ended March 2024, Cross Country Healthcare (CCRN) reported revenue of $379.17 million, down 39.1% over the same period last year. EPS came in at $0.19, compared to $0.84 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $373.73 million, representing a surprise of +1.46%. The company delivered an EPS surprise of +11.77%, with the consensus EPS estimate being $0.17.While investors closely watch year-over-year changes in headline numbers -- revenue and ear ...
Cross ntry Healthcare(CCRN) - 2024 Q1 - Quarterly Results
2024-05-01 20:27
CROSS COUNTRY HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS | --- | --- | --- | --- | --- | --- | --- | |----------------------------------------------------------------|-------|---------------------|-------|----------------------------------------------|-------|---------------------------------------| | Dollars are in thousands, except per share amounts \nRevenue | $ | Q1 2024 \n379,174 | | Variance Q1 2024 vs Q1 2023 \n(39) % | | Variance Q1 2024 vs Q4 2023 \n(8) % | | Gross profit margin* | | ...
Cross Country Healthcare to Attend the Oppenheimer 34th Annual Healthcare Conference
Businesswire· 2024-02-23 18:45
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) announced today that it is scheduled to participate in the Oppenheimer 34th Annual Healthcare Med-Tech & Services Conference taking place March 12-13, 2024. William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice President, Investor Relations, will participate in virtual one-on-one investor meetings on Tuesday, March 12, 2024. No formal presentation will be made. About Cross Co ...
Cross ntry Healthcare(CCRN) - 2023 Q4 - Annual Report
2024-02-22 16:00
31 Revenue increased $72.1 million, or 67.8% to $178.3 million for the year ended December 31, 2023, as compared to $106.2 million for the year ended December 31, 2022, primarily related to the Mint acquisition as well as an increase in volume in most specialties and an improved mix of higher bill rate specialties. Contribution income for the year ended December 31, 2023, increased $4.3 million or 77.7% to $9.8 million as compared to $5.5 million in the year ended December 31, 2022, driven by higher revenue ...
Cross Country CEO Featured on 2024 Staffing Industry Analysts' 100 in Staffing List
Businesswire· 2024-02-22 12:30
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, a market-leading, tech-enabled workforce solutions platform and advisory firm, is proud to announce that John A. Martins has been recognized on the Staffing Industry Analysts (SIA) Staffing 100 list of the most influential people in the industry. "I'm deeply honored to be included in the SIA's Staffing 100 list. This recognition is a testament to our team's commitment to driving innovation and excellence in the staffing industry,” said John A. ...
Cross Country (CCRN) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research· 2024-02-22 01:01
For the quarter ended December 2023, Cross Country Healthcare (CCRN) reported revenue of $414.04 million, down 34.1% over the same period last year. EPS came in at $0.29, compared to $1.09 in the year-ago quarter.The reported revenue represents a surprise of +2.88% over the Zacks Consensus Estimate of $402.44 million. With the consensus EPS estimate being $0.27, the EPS surprise was +7.41%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compar ...
Cross ntry Healthcare(CCRN) - 2023 Q4 - Earnings Call Transcript
2024-02-22 01:00
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q4 2023 Earnings Conference Call February 21, 2024 5:00 PM ET Company Participants Josh Vogel – Vice President-Investor Relations John Martins – President and Chief Executive Officer Bill Burns – Chief Financial Officer Marc Krug – Group President of Delivery Conference Call Participants Kevin Fischbeck – Bank of America Brian Tanquilut – Jefferies Trevor Romeo – William Blair Tobey Sommer – Truist Securities Constantine Davides – Citizens JMP Kevin Steinke – Ba ...
Cross ntry Healthcare(CCRN) - 2023 Q4 - Annual Results
2024-02-20 16:00
BOCA RATON, Fla., February 21, 2024--Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2023. * Represents amounts that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP) and are referred to as non-GAAP measures. Please refer to the accompanying discussion of how these non-GAAP financial measures are calculated and used under "Non-GAAP Financial Measures" and tables re ...
Curious about Cross Country (CCRN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Zacks Investment Research· 2024-02-19 15:21
Wall Street analysts expect Cross Country Healthcare (CCRN) to post quarterly earnings of $0.27 per share in its upcoming report, which indicates a year-over-year decline of 75.2%. Revenues are expected to be $402.44 million, down 35.9% from the year-ago quarter.Over the last 30 days, there has been an upward revision of 1.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course ...